UnitedHealth Reports Q1 Earnings Beat at $6.90 Despite 965K Medicare Losses
UnitedHealth Group (NYSE: UNH) delivered first-quarter earnings that exceeded Wall Street expectations despite significant membership losses in its crucial Medicare Advantage business. The health insurance giant reported earnings per share of $6.90, with adjusted earnings of $7.23 per share, beating analyst consensus while navigating a challenging operating environment.
Key Numbers
The company posted first-quarter revenue of $111.7 billion, up 2% year-over-year from $109.6 billion, though growth decelerated from recent quarters. Net income reached approximately $6.3 billion based on the reported EPS and share count, delivering a net margin of 5.6%, slightly down from 5.7% in the prior year period.
The most striking metric was the loss of 965,000 Medicare Advantage members during the quarter, a significant erosion in what has traditionally been UnitedHealth's growth engine. Total membership across all lines declined to 49.1 million from 49.8 million at year-end 2025. Despite these headwinds, the company's medical care ratio improved to 83.9%, down 90 basis points from 84.8% in Q1 2025, indicating better cost management.
Operating cash flow remained robust at $8.9 billion, representing 1.4 times net income, while the debt-to-capital ratio improved to 42.9% from 44.6% a year ago. The company raised its full-year 2026 adjusted earnings guidance to greater than $18.25 per share, suggesting confidence in its turnaround efforts.
What Management Said
CEO Stephen Hemsley emphasized the company's strategic pivot, stating they are "continuing to help simplify and modernize health care for the people and care providers we serve, bringing greater value, affordability, transparency and connectivity." This messaging aligns with UnitedHealth's broader restructuring initiative launched in the second half of 2025.
Management highlighted several strategic actions taken during the quarter, including a complete refocus on U.S. healthcare with exits from non-U.S. businesses. The company completed the sale of its Optum UK business for $400 million in net proceeds, which will be directed to the United Health Foundation. Additionally, UnitedHealth refreshed nearly half of its top 100 leadership roles, signaling a significant management overhaul.
The company also announced an agreement to acquire Alegeus Technologies, a healthcare technology platform for consumer-directed healthcare accounts, though management expects this to be earnings neutral for 2026. A $2 billion share buyback program was initiated, expected to be completed by the end of Q2 2026.
Regarding the Medicare losses, management attributed the decline to "trend-driven repricing actions" — essentially raising premiums in response to elevated medical costs, which led to member attrition. The company characterized medical cost trends as "elevated but in line with expectations," suggesting they had anticipated these challenges.
What to Watch
The Medicare Advantage membership hemorrhage stands as the most critical issue facing UnitedHealth. With nearly one million members lost in a single quarter, investors will closely monitor whether the company can stabilize this business or if further losses are ahead. The 2027 Medicare Advantage bidding season will be crucial in determining whether UnitedHealth can return to growth.
The elevated operating cost ratio of 13.8%, up from 12.4% a year ago, reflects heavy investments in artificial intelligence, cybersecurity, and operational improvements. While management frames these as necessary modernization efforts, investors will want to see these investments translate into improved margins and member retention.
Optum Health's adjusted operating margin of 5.4% remains below historical levels, though management notes operational improvements. The unit continues to work through "third-party loss contracts" that have pressured results, with a $137 million reduction in provisions this quarter providing some relief.
The company's goal to reach a 40% debt-to-capital ratio by the second half of 2026 appears achievable given current trajectory, but this depends on maintaining strong cash generation amid membership pressures. Days claims payable increased to 48.6 from 44.1 sequentially, which management attributed to seasonality, but bears watching for any signs of claims processing delays.
Finally, the broader strategic repositioning — including the exit from international markets, leadership changes, and technology investments — represents a multi-year transformation. Success will be measured not just in financial metrics but in the company's ability to reverse market share losses while improving both provider and consumer satisfaction in an increasingly competitive managed care landscape.